Volkova et al. [35] claim that serum Ang-2 levels were a stronger predictor of survival than serum VEGF-A levels, which are the main angiogenic factor associated with poor colorectal cancer outcomes [45]. The gene discussed is VEGFA; the disease is colorectal cancer.